NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,406,116 | +9.6% | 2,296,000 | -6.0% | 0.28% | +28.0% |
Q2 2023 | $3,108,728 | -44.8% | 2,443,000 | -41.8% | 0.22% | -44.8% |
Q1 2023 | $5,627,603 | -27.4% | 4,195,000 | -14.6% | 0.40% | -19.6% |
Q4 2022 | $7,748,506 | +61.3% | 4,915,000 | +43.6% | 0.49% | +52.5% |
Q3 2022 | $4,803,000 | +1652.9% | 3,423,000 | +1553.6% | 0.32% | +1688.9% |
Q2 2021 | $274,000 | -2.1% | 207,000 | -1.0% | 0.02% | -10.0% |
Q1 2021 | $280,000 | -2.8% | 209,000 | 0.0% | 0.02% | -4.8% |
Q4 2020 | $288,000 | -96.4% | 209,000 | -96.5% | 0.02% | -97.0% |
Q3 2020 | $8,100,000 | -21.8% | 5,888,000 | -5.4% | 0.70% | -22.9% |
Q2 2020 | $10,354,000 | +86.4% | 6,226,000 | +43.7% | 0.91% | +85.1% |
Q1 2020 | $5,554,000 | -42.6% | 4,334,000 | -31.4% | 0.49% | -23.9% |
Q4 2019 | $9,675,000 | +7.4% | 6,317,000 | -4.0% | 0.64% | -1.8% |
Q3 2019 | $9,011,000 | -4.6% | 6,582,000 | -8.6% | 0.66% | -6.6% |
Q2 2019 | $9,450,000 | -6.0% | 7,202,000 | -3.2% | 0.70% | -16.6% |
Q1 2019 | $10,058,000 | +9.7% | 7,440,000 | -3.1% | 0.84% | -1.9% |
Q4 2018 | $9,168,000 | -40.2% | 7,680,000 | -14.5% | 0.86% | -27.3% |
Q3 2018 | $15,319,000 | +21.5% | 8,987,000 | +2.9% | 1.18% | +14.5% |
Q2 2018 | $12,609,000 | – | 8,736,000 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |